- Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation
2006/07/06 by Frank C. Chen, Ozgur Ogut, Albert Y. Rhee +2 · 8 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · #Antagonist #Blood pressure #Captopril #Cardiology #Chemistry #Endocrinology #Internal medicine #Ion channel regulation and function #Medicine #Myosin #Myosin light-chain kinase #Myosin-light-chain phosphatase #Nitric Oxide and Endothelin Effects #Prazosin #Receptor #Renin-Angiotensin System Studies #Renin–angiotensin system #Vasoconstriction #Vasodilation
- Angiotensin II and trials of cardiovascular outcomes11Reprints are not available.
2002/01/01 by Peter Sleight · 8 citations
Medicine · #ACE inhibitor #Angiotensin II #Angiotensin-converting enzyme #Blood Pressure and Hypertension Studies #Blood pressure #Captopril #Cardiology #Enalapril #Heart Failure Treatment and Management #Heart failure #Hormonal Regulation and Hypertension #Hypertensive heart disease #Internal medicine #Medicine #Myocardial infarction #Ramipril #Trandolapril
- Facilitation of renal kallikrein–kinin system prevents the development of hypertension by inhibition of sodium retention
1999/10/01 by Masataka Majima, Izumi Hayashi, Tomoe Fujita +3 · 1 citation
Chemistry · Medicine · #Biochemistry #Blood pressure #Bradykinin #Captopril #Chemistry #Coagulation, Bradykinin, Polyphosphates, and Angioedema #Endocrinology #Enzyme #Essential hypertension #Hormonal Regulation and Hypertension #Internal medicine #Kallikrein #Kinin #Kininogen #Medicine #Receptor #Renin-Angiotensin System Studies